Research recruitment through US central cancer registries: Balancing privacy and scientific issues

American Journal of Public Health

Volumn 96, Issue 11, 2006, Pages 1920-1926

  Beskow, Laura M ^a   Sandler, Robert S ^c   Weinberger, Morris ^a,b  

^a IL   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; CANCER RESEARCH; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MEDICAL RESEARCH; PATIENT EDUCATION; PATIENT RIGHT; PHYSICIAN ATTITUDE; POPULATION BASED CASE CONTROL STUDY; PRIVACY; REVIEW; UNITED STATES;

CERTIFICATION; CONFIDENTIALITY; ETHICS COMMITTEES, RESEARCH; HEALTH CARE SURVEYS; HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT; HUMANS; NEOPLASMS; OBSERVATION; ORGANIZATIONAL POLICY; PATIENT EDUCATION; PATIENT SELECTION; PHYSICIAN'S ROLE; PUBLIC HEALTH; RESEARCH SUPPORT; RESIDENCE CHARACTERISTICS; SEER PROGRAM; STATE GOVERNMENT; UNITED STATES;

EID: 32944462090     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2004.061556     Document Type: Review

References (38)

1. Howe HL, Edwards BK, Young JL, et al. A vision for cancer incidence surveillance in the United States. Cancer Causes Control. 2003;14:663-672.
2. Wingo PA, Jamison PM, Hiatt RA, et al. Building the infrastructure for nationwide cancer surveillance and control - a comparison between the National Program of Cancer Registries (NPCR) and the Surveillance, Epidemiology, and End Results (SEER) program (United States). Cancer Causes Control. 2003;14:175-193.
3. Izquierdo JN, Schoenbach VJ. The potential and limitations of data from population-based state cancer registries. Am J Public Health. 2000;90:695-698.
4. Hankey BF, Ries LA, Edwards BK. The Surveillance, Epidemiology, and End Results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
5. Swan J, Wingo P, Clive R, et al. Cancer surveillance in the US: can we have a national system? Cancer. 1998;83:1282-1291.
6. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Available at http://seer.cancer.gov/. Accessed May 31, 2005.
7. Centers for Disease Control and Prevention. National Program of Cancer Registries. Available at http://www.cdc. gov/cancer/npcr/index.htm. Accessed May 31, 2005.
8. Hiatt RA, Rimer BK. A new strategy for cancer control research. Cancer Epidemiol Biomarkers Prev. 1999;8:957-964.
9. UNC Lineberger Comprehensive Cancer Center. Rapid case ascertainment. Available at http://cancer.med.unc.edu/research/cores/fadlity.asp?facilityID=17. Accessed May 31, 2005.
10. North American Association of Central Cancer Registries. Available at http://www.naaccr.org/. Accessed May 31, 2005.
11. Florida Cancer Data System. Procedure guide for studies that utilize FCDS for patient identification and contact. Available at http://fcds.med.miami. edu/inc/datarequest.shtml. Accessed May 31, 2005.
12. Newman B, Moorman PG, Millikan R, et al. The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat. 1995;35:51-60.
13. Shaheen NJ, Silverman LM, Keku T, et al. Association between hemochromatosis (HFE) gene mutation carrier status and the risk of colon cancer. J Natl Cancer Inst. 2003;95:154-159.
14. Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999;91:1719-1724.
15. American Cancer Society Behavioral Research Center. Study of Cancer Survivors I & II. Available at http://www.cancer.org/docroot/res/content/ res_9_1_brc_survivorship_research.asp? sitearea=res. Accessed May 31, 2005.
16. National Cancer Institute Cancer Control and Population Sciences. Cancer Care Outcomes Research and Surveillance Consortium. Available at http://healthservices.cancer.gov/cancors/. Accessed May 31, 2005.
17. Moorman PG, Newman B, Millikan RC, Tse CK, Sandler DP. Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol. 1999;9:188-195.
18. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the Protection of Human Subjects of Research. Washington DC: US Government Printing Office; 1979.
19. US Dept of Health and Human Services. Federal Policy for the Protection of Human Subjects (45 CFR 46). Available at http://www.hhs.gov/ohrp/ humansubjects/guidance/45cfr46.htm. Accessed May 31, 2005.
20. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Int Bioethique. 2004;15:124-129.
21. Beskow LM, Botkin JR, Daly M, et al. Ethical issues in identifying and recruiting participants for familial genetic research. Am J Med Genet. 2004;130A:424-431.
22. Capron AM. Protection of research subjects: do special rules apply in epidemiology? J Clin Epidemiol. 1991;44(suppl 1):81S-89S.
23. Kulynych J, Korn D. The effect of the new federal medical-privacy rule on research. N Engl J Med. 2002;346:201-204.
24. National Cancer Institute Surveillance Implementation Group. Cancer Surveillance Research Implementation Plan. Available at http://cancercontrol. cancer.gov/sig/. Accessed May 31, 2005.
25. Hewitt M, Simone JV, eds. Ensuring Quality of Cancer Care. National Cancer Policy Board, Institute of Medicine. Washington, DC: National Academy Press; 1999.
26. Harris KA. The informational needs of patients with cancer and their families. Cancer Pract. 1998;6:39-646.
27. Moody R. Overcoming barriers to delivering information to cancer patients. Br J Nurs. 2003;12:1281-1287.
28. Gurwitz JH, Guadagnoli E, Landrum MB, Silliman RA, Wolf R, Weeks JC. The treating physician as active gatekeeper in the recruitment of research subjects. Med Care. 2001;39:1339-1344.
29. Savitz DA, Hamman RF, Grace C, Stroo K. Respondents' attitudes regarding participation in an epidemiologic study. Am J Epidemiol. 1986;123:362-366.
30. Sugarman J, Regan K, Parker B, Bluman LG, Schildkraut J. Ethical ramifications of alternative means of recruiting research participants from cancer registries. Cancer. 1999;86:647-651.
31. Boring CC, Brockman E, Causey N, Gregory HR, Greenberg RS. Patient attitudes toward physician consent in epidemiologic research. Am J Public Health. 1984;74:1406-1408.
32. Meslin EM. The recruitment of research participants and the role of the treating physician. Med Care. 2001;39:1270-1272.
33. Beskow LM, Sandler RS, Millikan RC, Weinberger M. Patient perspectives on research recruitment through cancer registries. Cancer Causes Control. 2005;16:1171-1175.
34. Dicker BG, Kent DL. Physician consent and researchers' access to patients. Epidemiology. 1990;1:160-163.
35. Herrmann N, Amsel J, Lynch E. Obtaining hospital and physician participation in a case-control study of colon cancer. Am J Public Health. 1981;71:1314-1319.
36. Helmes AW, Bowen DJ, Bowden R, Bengel J. Predictors of participation in genetic research in a primary care physician network. Cancer Epidemiol Biomarkers Prev. 2000;9:1377-1379.
37. Rimer BK, Schildkraut JM, Lerman C, Lin TH, Audrain J. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer. 1996;77:2348-2355.
38. National Bioethics Advisory Commission. Research Involving Human Biological Materials: Ethical Issues and Policy Guidance, Volume 1. Rockville, Md: National Bioethics Advisory Commission: 1999.